Table 2.
Detection rates of viral nucleic acid in samples taken from the upper airways of dogs with and without CIRD
| Pathogen | Group | Total diseased dogs (n=214) | A (n=173) | B (n=41) | C (n=50) |
|---|---|---|---|---|---|
| CRCoV | n (% dogs) 95% CI | 16 (7.5) 4.0 ‐ 11.0 | 9 (5.2) 1.9 ‐ 8.5 | 7 (17.0) 5.6 ‐ 28.6 | 2 (4.0) 0.0 ‐ 9.4 |
| CPiV | n (% dogs) 95% CI | 14 (6.5) 3.2 to 9.9 | 11 (6.4) 2.7 to 10.0 | 3 (7.3) 0.0 to 15.3 | 0 (0.0) |
| CAV‐2 | n (% dogs) 95% CI | 1 (0.5) 0.0 to 1.4 | 1 (0.6) 0.0 to 1.7 | 0 (0.0) | 0 (0.0) |
| CDV | n (% dogs) 95% CI | 1 (0.5) 0.0 to 1.4 | 1 (0.6) 0.0 to 1.7 | 0 (0.0) | 0 (0.0) |
| CIV | n (% dogs) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
CIRD Canine infectious respiratory disease, CRCoV Canine respiratory coronavirus, CPiV Canine parainfluenza virus, CAV‐2 Canine adenovirus type‐2, CDV Canine distemper virus, CIV Canine influenza virus, Group A Privately owned diseased dogs, Group B Kennelled diseased dogs, Group C Healthy control group, CI Confidence interval
Comparing group A and group B, significantly more CRCoV positives were found within shelters (P<0.009)